October 2026 – Page 19 – HEATHCARE BRIEFING

Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road caribou-bio’s-journey-with-off-the-shelf-cell-therapy-reaches-the-end-of-the-road

Caribou Bio’s Journey With Off-the-Shelf Cell Therapy Reaches the End of the Road

admin Posted on 1 week ago

Caribou Biosciences has an off-the-shelf cell therapy with encouraging clinical data to date and agreement with the...

STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare stat+:-phrma-sues-over-trump-policy-mandating-lower-drug-prices-in-medicare

STAT+: PhRMA sues over Trump policy mandating lower drug prices in Medicare

admin Posted on 1 week ago

Pilot program known as GLOBE is intended to test ‘most-favored nation’ policy Jenny Kane/AP By John Wilkerson...

Constant Vigilance is the Watchword for Healthcare AI Governance constant-vigilance-is-the-watchword-for-healthcare-ai-governance

Constant Vigilance is the Watchword for Healthcare AI Governance

admin Posted on 1 week ago

A webinar moderated by MedCity News Editor-in-Chief Arundhati Parmar delved into findings of the recently published Healthcare...

STAT+: Merck suffers a setback in Europe over its new Keytruda formulation stat+:-merck-suffers-a-setback-in-europe-over-its-new-keytruda-formulation

STAT+: Merck suffers a setback in Europe over its new Keytruda formulation

admin Posted on 1 week ago

By Ed Silverman Oct. 7, 2026 Pharmalot Columnist, Senior Writer Ed’s stories explore prescription drug pricing, affordability...

STAT+: Forbion raises $2.6 billion, its largest fundraise to date stat+:-forbion-raises-$2.6-billion,-its-largest-fundraise-to-date

STAT+: Forbion raises $2.6 billion, its largest fundraise to date

admin Posted on 1 week ago

Promising Duchenne therapies will test FDA flexibility, Doudna-founded Caribou shutting down, and more biotech news Adobe Elaine’s...

PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs? pbm-transparency-is-still-too-opaque-—-how-can-employers-rein-in-drug-costs?

PBM Transparency Is Still Too Opaque — How Can Employers Rein In Drug Costs?

admin Posted on 1 week ago

Healthcare premiums are expected to jump another 9% in 2027. The cost of care is reaching a...

STAT+: Why health AI pilots in Utah may be on a collision course with the FDA stat+:-why-health-ai-pilots-in-utah-may-be-on-a-collision-course-with-the-fda

STAT+: Why health AI pilots in Utah may be on a collision course with the FDA

admin Posted on 1 week ago

You’re reading the web edition of STAT’s AI Prognosis newsletter STAT/Adobe Brittany Trang, Ph.D., covers AI in...

Teladoc Health Unveils SoloVitals and SoloScribe: AI-Powered Contactless Biometrics and Enterprise Documentation teladoc-health-unveils-solovitals-and-soloscribe:-ai-powered-contactless-biometrics-and-enterprise-documentation

Teladoc Health Unveils SoloVitals and SoloScribe: AI-Powered Contactless Biometrics and Enterprise Documentation

admin Posted on 1 week ago

What You Should Know Enterprise virtual care leader Teladoc Health launches two native AI-powered capabilities integrated directly...

From Distributor to Disruptor: Amazon’s Healthcare Flex from-distributor-to-disruptor:-amazon’s-healthcare-flex

From Distributor to Disruptor: Amazon’s Healthcare Flex

admin Posted on 1 week ago

Could this be Big Tech’s ultimate healthcare flex? For years, Amazon’s ambitions in this $4 trillion market...

Texas attorney general investigates UnitedHealth over care denials texas-attorney-general-investigates-unitedhealth-over-care-denials

Texas attorney general investigates UnitedHealth over care denials

admin Posted on 1 week ago

Ken Paxton is on the hunt for evidence that UnitedHealth is breaking the Deceptive Trade Practices Act...